H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: AXSM) | Delayed: 156.31 -3.27 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $159.58 | 52 Week High | $15.74 | |||
| Open | $158.83 | 52 Week Low | $5.37 | |||
| Day High | $160.82 | P/E | N/A | |||
| Day Low | $156.04 | EPS | $0.00 | |||
| Volume | 524,790 | |||||
